Fundz

Ovid Therapeutics Inc. reported raising $75 Million in an initial SEC Form D filing, from an offering of $75 Million

PUBLIC · OVIDAug 18, 2015

Amount Raised

$75 Million

$75 Million sold, per SEC Form D (first sale Aug 18, 2015)

Round Type

Venture

New YorkBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Ovid Therapeutics raised $75 Million in a funding round, dated August 18, 2015. Ovid Therapeutics is based in New York, New York, United States.

How much did Ovid Therapeutics raise?
Ovid Therapeutics raised $75 Million in a funding round on August 18, 2015.
What does Ovid Therapeutics do?
Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions.
Where is Ovid Therapeutics based and how big is it?
Ovid Therapeutics is based in New York, New York, United States. Fundz records about 23 employees.
Who are the decision-makers at Ovid Therapeutics?
Fundz holds 1 contact at Ovid Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Ovid Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Deciphera Pharmaceuticals raised $22M on September 29, 2015.
  • Corvus Pharmaceuticals, Inc. raised $75M on September 25, 2015.
  • Wave Life Sciences raised $66M on August 28, 2015.
  • Rhythm Pharmaceuticals raised $25M on August 12, 2015.
  • CytoDyn raised $2M (Seed) on July 14, 2015.
  • Eximis Surgical raised $270K (Seed) on September 23, 2015.

Who to call at Ovid Therapeutics, and when

A new round usually means Ovid Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ovid Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ovid Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ovid Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ovid Therapeutics

Location

New York, New York, United States

About

Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures. At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside. Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ovid Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts7 people are listed at Ovid Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ovid Therapeutics's next move

See what Strategic adds

Ovid Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.